NOV 04, 2016 10:00 AM PDT

Applying a multi-omics approach to tumor biomarker discovery - case studies

Sponsored by: Affymetrix, Affymetrix
Speakers
  • Assistant Professor, Department of Obstetrics, Gynecology & Reproductive Sciences; Yale School of Medicine
    Biography
      Dr. Yang Yang received her PhD degree from Nankai University. She is currently an Assistant Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine.
    • Associate Professor of Pathology and Oncology; Johns Hopkins University School of Medicine
      Biography
        Dr. Tamara Lotan received her MD degree from the University of Chicago Pritzker School of Medicine. She is currently an Associate Professor of Pathology and Oncology at the Johns Hopkins University School of Medicine.
      • Professor of Pathology and Cell Biology; Columbia University
        Biography
          Dr. Antonia R. Sepulveda received her MD degree from University of Lisbon and her PhD degree from Baylor College of Medicine. She is Professor of Pathology and Cell Biology, Vice Chair for Translational Research, and Director, Division of Gastrointestinal Pathology at Columbia University.

        Abstract
        DATE:  November 4, 2016
        TIME:  10:00am PT, 1:00pm ET

        How do you develop clinically relevant biomarkers?

        Systematic tumor profiling with multi-omics tools and rapid analytical validation is a powerful way to discover clinically relevant biomarkers and increase the probability of success. The parallel analysis of any combination of SNP, copy number variation, gene expression and regulation, protein expression, or cellular analysis enables rapid identification of the most robust biomarkers for impactful clinical application. The data from one type of analyte can provide biological validation for another, enhancing the diagnostic power and increasing confidence in the final biomarkers selected towards routine clinical use.

        During this webinar, three translational researchers will:
        • Discuss their experience applying a multi-omics approach to tumor profiling in ovarian, pancreatic, and prostate cancers 
        • Demonstrate the use of advanced technologies enabling rapid efficient biomarker discovery and validation at the DNA, RNA, protein, and cellular levels
        • Explain how the Affymetrix Tumor Profiling Grant has allowed them to undertake important projects aimed at improving cancer treatment that otherwise would not have come to fruition
        • Answer your questions live during the broadcast!
        Learning Objectives:
        • Understand how a multi-omics approach can increase confidence in cancer biomarker discovery
        • Gain exposure to new translational research tools for whole-genome and whole-transcriptome profiling

        Show Resources
        You May Also Like
        MAY 11, 2021 10:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        C.E. CREDITS
        MAY 11, 2021 10:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
        NOV 16, 2020 8:00 AM PST
        C.E. CREDITS
        NOV 16, 2020 8:00 AM PST
        Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
        JUN 09, 2021 7:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        C.E. CREDITS
        JUN 09, 2021 7:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
        APR 01, 2021 8:00 AM PDT
        C.E. CREDITS
        APR 01, 2021 8:00 AM PDT
        Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
        DEC 02, 2020 8:00 AM PST
        C.E. CREDITS
        DEC 02, 2020 8:00 AM PST
        DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
        MAR 18, 2021 8:00 AM PDT
        C.E. CREDITS
        MAR 18, 2021 8:00 AM PDT
        DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
        Loading Comments...
        Show Resources
        Attendees
        • See more